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BREAST TUMOR SIZE AT FIRST PRESENTATION IN HAITIAN BREAST 
CANCER PATIENTS TREATED IN A LARGE U.S. SAFETY NET HOSPITAL: 
INITIAL RESULTS  
FAOZ HASHM 
ABSTRACT 
 This study assessed the tumor size at the time of first presentation of Haitian 
breast cancer patients compared to Non-Haitian Black and White patient populations of a 
large safety net hospital as an objective measure of diagnosis and treatment delay.  
Studies have shown that race and ethnicity have an influence in determining the breast 
cancer stage, treatment, and mortality rates.  However, when we looked at the rates of 
breast cancer, screening among Black subgroups, such as Haitian women, was assessed 
and remained unclear because national studies do not differentiate Haitians from other 
Black populations.  Two population-based studies that investigated breast cancer 
screening among Haitian women suggest that screening rates among Haitian women are 
lower than that of White and Black women.  For this reason, many studies are diagnosed 
at later stages.  This study to aimed to improved patient education. In this IRB approved 
retrospective study used the hospital electronic medical records and the cancer registry of 
breast cancer patients treated between 2013-2015.  Female and male patients with 
primary breast cancer treated with surgery, complete imaging and medical data sets were 
included; patients with recurrent breast cancer or incomplete data sets were excluded.  
Demographics/race/ethnicity, tumor type and stage, receptor status, onco-type, 
proliferation rate as well as tumor size by radiology and pathology were recorded.  
		 vii 
Statistical analysis using ANOVA, T-test, U-test and Kruskal-Wallis, compared mean 
and median tumor sizes. In this study only tumor size was analyzed and reported.  The 
results show 57/125 (45.6%) Haitian Black patients, 27/125 (21.6%) Non-Hispanic 
White, 41/125 (32.8%), Non-Haitian Black were included in the initial analysis of this 
study.  The mean tumor size of Haitian Black (mean=3.09 cm, SD 2.91; median=2.3cm) 
was significantly larger compared to Black (mean=2.07cm, SD=1.77; median=1.6cm; 
p=0.022) or White (mean=1.88, SD=1.26; median=1.4; p = 0.008) patients.  There was 
no significant difference in tumor size between Non-Haitian Black and White patients. 
Haitian Breast Cancer patients present with significantly larger tumors when compared to 
other patient populations.  Improved patient education and intensified out-reach programs 
are needed to counteract this marked delay in initial diagnosis and treatment. 
Education and socio-economic differences must be further evaluated and all possible 
cofactors are needed to determine the most effective interaction to counteract this 
disparity. 
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INTRODUCTION 
 
 Breast cancer can develop from all cells of the breast.  Commonly cancer starts with 
the inside parts of the linings of milk ducts, lobules.  Breast cancer is one of the most 
occurring cancers and is considered the second principal cause of cancer-related deaths 
among women.  Studies have shown that race and ethnicity have an influence in 
determining the breast cancer stage, treatment, and mortality rates (Wilcox et al., 2016). 
Breast cancer is a common invasive cancer in female across the world.  About 
16% of the female cancers are breast cancer.  About 18.2% (Management of breast 
cancer in older women, 2011) of the cancer deaths were caused by breast cancer 
worldwide, including all females and males.  In developed nations, cancer rates are 
higher than compared to the developing nations because of the variance in lifestyle.  
Senior women are more vulnerable compared to young women due to the weakening of 
the immune systems caused by aging (Management of breast cancer in older women, 
2011).  The variance in the eating habits of the developing nations is the causes of the 
differences in the rate of breast cancer vulnerabilities.  
A mature woman has fats in the breast connective tissues and more lobules; the 
tiny glands that produce milk.  The breast is like any other part of the body, made of 
billions of microscopic cells thus the cells duplicate systematically because whenever a 
cell dies another cell is developed to replace the dead cell (Philpotts, Liane, and Regina, 
2016).  Therefore, due to the generation of billions of cells, cancer can duplicate 
uncontrollably in this environment.  Breast cancer most commonly starts at the 
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lactiferous duct or the milk duct ductal carcinoma and it is the most common kind type of 
breast cancer. 
 An estimated 234,190 new breast cancer cases and 40,473 breast cancer deaths 
were expected in the United States in 2015 (Siegel, Miller, & Jemal, 2015).  Prior to 
2015, the American Cancer Society (ACS) recommended an annual mammogram starting 
at age 40 for women at average risk of breast cancer for early detection of the cancer 
(Smith et al., 2003). 
 Although screening cannot prevent the development of breast cancer, routine use 
of mammogram has been shown to increase survival via early detection and early 
treatment of the cancer (Independent UK Panel on Breast Cancer Screening, 2012).  
Although breast cancer is lower among Black women compared with White women, 
higher mortality rates are noted among Black women partly due to being diagnosed at 
later stages and to having lower stage-specific survival rates.  Black women also 
generally experience a higher burden of poverty and lack of insurance compared to White 
women (Alcazar-Bejerano, 2014). 
  Studies have shown that Black women have less knowledge of breast cancer, 
greater fear of mammograms, and of being diagnosed with cancer this increases cancer 
fatalism compared White women (Albain et al., 2009; Menashe et al., 2009).  In addition, 
Black women who do not get mammograms reported low self-efficacy, perceived more 
barriers to mammograms, perceived fewer benefits of mammograms.  Additionally,  
shows lower perceived susceptibility to cancer compared with Black women who did 
complete mammogram ; Du & Simon, 2005). 
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 Rates of breast cancer screening among Black subgroups, such as Haitians, 
remain unclear because national studies do not differentiate Haitians from other Black 
populations.  Two population-based studies that investigated breast cancer screening 
among Haitian women suggest that screening rates among Haitian women are lower than 
that of White and Black women (Alcazar-Bejerano 2014; Kobetz et al., 2010; 
Mandelblatt et al., 1999). 
Background 
 In practice, the elimination of disparities is defined as a reduction in cancer 
incidence and mortality and an increase in cancer survival among socioeconomically 
disadvantaged people to levels comparable to those in the general population (Ward et 
al., 2004).  The age specific breast cancer incidence rate for African-American women 
under age 35 is more than twice the rate for white women of similar age and the mortality 
rate is more than three times higher.  To determine factors that may explain racial/ethnic 
variation in outcomes among young women diagnosed with breast cancer, the authors 
examined the clinical presentation, treatment, and survival of African-American, 
Hispanic, and White women under age 35 years.  The lower breast cancer incidence in 
minority women and the higher breast cancer mortality in African American women than 
in white women were largely unexplained (Shavers, Harlan, & Stevens 2003;Wilcox et 
al., 2016). 
 Haitians also face a number of difficulties related to screening, including social-
cultural factors, an absence of financial resources/insurance, language difficulties, and 
fear of cancer diagnosis and medical treatment.  Some studies showed that the 
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socioeconomic status also has an effect on immigrants with breast cancer (Kobetz et al., 
2011; Newman et al., 2006). 
 Furthermore, other studies have determined that black women tend to be 
diagnosed at later stages which has led to higher mortality rates.  This has been shown in 
spite of the lower overall incidence of breast cancer among Black women when 
compared  With white women (Newman et al., 2006).  In addition, research has shown 
that Black women have less education of breast cancer and a greater fear of receiving 
routine screening of the breast (Chlebowski et al., 2005).  The influence of ethnicity as a 
risk factor for breast cancer has received inadequate attention (Alcazar-Bejerano, 2014).  
The purpose of this study was to assess the tumor size at the time of first presentation in 
Haitian breast cancer patients compared to Non-Haitian Black and White patient 
population of a large safety net hospital, as an objective measure of diagnosis and 
treatment delay. 
Symptoms of Breast Cancer 
The patient can feel symptoms such as pain or a headache.  A headache is 
common as reported by most cancer doctors during the initial stages.  The patient can 
encounter a persistent headache, unlike a normal headache that lasts for some few hours.  
The rush or selling is also a common symptom of breast cancer.  The thickening of the 
breast tissues in the breast or the development of lumps are the major signs of breast 
cancer some lumps are not cancerous.  Therefore, it is important to check with the doctor 
whenever a lump is observed in the breast.  
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Pain in the armpits is common during the menstrual period. However, persistent 
pain in the armpits can be a symptom of breast cancer.  Thus women supposed to consult 
doctors when experiencing abnormal armpit pains.  The persistent menstrual cycle does 
not have a connection with the monthly periods is also thus, symptom.  Persistent 
menstrual bleeding occurs.  
Some of the features that change in the breast include the nipple appearance.  The 
nipple can start to discharge some blood and sink or get inverted from the normal 
position.  The sunken breast is not normal to most women, especially young women who 
have not breastfed.  The size of the breast also changes gradually due to the invasion of 
the cells.  
Breast Cancer Risk 
 
Breast cancer is among the many cancer diseases targeting various body organs. 
Depending on the stage of the disease in the human body, cancer can be controlled in the 
initial stages.  Advanced stages of cancer may not be curable or manageable, thus 
resulting in terminal illness.  The Society has been being largely educated on the control 
and prevention of breast cancer.  The causes of cancer either can be hereditary or can be 
acquired from certain lifestyles adopted by individuals.  Many risk factors for cancer are 
known and largely related to human lifestyles.  In the contemporary society, the various 
cancers, including breast cancer, are among the leading killer diseases (Mateen, 2015). 
Causes and risk factors of cancer could include old age, use of alcohol, uncontrolled 
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human weight, inheritance, height, ethnicity, body hormones, and the age that one started 
or stopped having monthly menstrual periods. 
As people have grown older, there has been an upsurge in the chances of getting 
breast cancer.  According to statistical data on women who have had breast cancer, only 
two out of every ten women who have devloped breast cancer are below the age of fifty 
years old.  The data, therefore, shows a greater percentage of older women suffering from 
breast cancer than younger women below the age of fifty or women who have yet to 
reach menopause (Mateen, 2015).  Also, the age at which a woman started or stopped 
having the monthly menstrual periods is a factor towards the risk of breast cancer.  There 
is an increased chance of getting cancer in two scenarios about the age at which one 
started or stopped having monthly menstrual periods.  Women who started having their 
periods before the age of twelve and those women who stopped having their periods after 
the age of 55 have a higher risk of breast cancer.  Estrogen hormone levels are also 
related to the risk of cancer. 
A woman’s body weight and height also has a bearing on one’s risk towards 
cancer.  Women who are overweight after reaching menopause have a higher risk of 
breast cancer compared to women who have a healthier body mass index.  Physical 
fitness and adopting a healthy diet may decrease the chances of contracting breast cancer.  
The difference in hormonal levels between women who are shorter and women who are 
taller than average can contrbute towred a higher risk of breast cancer.  Ethnicity has also 
been linked to the breast cancer risk.  White women have a higher risk of breast cancer 
than women from other ethnic groups.  The high prevalence of breast cancer in the White 
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women can be largely attributed to genetic predisposition and lifestyle.  Alcohol is also 
related to the high risk of breast cancer among women consuming alcohol.  For example, 
every pint of beer, which is equivalent a unit of alcohol, increases the risk of breast 
cancer (Matane, 2015). 
Screening for Breast Cancer   
Mammography is a form of imaging under the use of low power x-rays that is 
used for delicate body parts like breast tissues.  Due to the high sensitivity of the 
modality, it is mostly used for screening and detection of early stages of breast cancer.  
The study of breasts is done under the use of mammography modality that utilizes a 
standardized view of the breasts that offers a good view of the structure (Ikeda, Debra, 
and Kanae, 2016).  
Clinical applications of mammography (World Health Organization, 2017) 
• Mammography screening: the process is used to detect the early stages breast 
cancer.  The process is used in asymptomatic women.  
• Mammography diagnosis: the imaging of breasts on the diagnosis of the 
suspected cancer symptoms that were previously recognized 
• Mammography surveillance: the process is used do an assessment for the future 
recurrence of malignancy breast cancer that is unknown. 
• Tumor marking and needle localization: tissue samples are obtained from the 
selection of breasts with suspicious signs of cancer on screening or 
mammography diagnosis.  The tumor is done through surgery.  
The preparation of a mammogram (Carrio & Ros, 2014) 
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• It is suggested to use a facility that performs more mammograms on a day when 
one has a choice.  
• The same facility must be used every time the mammograms are tested for an 
easy comparison with the previous results.  
• When visiting a facility for the first time, it is recommended to carry the previous 
results from other facilities.  The treatment offered and the biopsies can help the 
diagnosing officer to come up with a clear decision on the condition of cancer.  
• Any time a new mammogram facility is visited, the previous records from other 
mammograms must be carried by the patient. 
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METHODS  
 
In this study, the records of 50 Haitian-born, 50 USA-born White, and 50 USA-
born Black patients diagnosed with breast cancer were compared to assess the association 
between race/ethnicity and aggressiveness of the cancer including size, number of 
lesions, and tumor stage.  Female and male patients with primary breast cancer treated 
with surgery, complete imaging and medical data sets were included; patients with 
recurrent breast cancer or incomplete data sets were excluded. 
Demographics/race/ethnicity, tumor type and stage, receptor status, onco-type, 
proliferation rate as well as tumor size by radiology and pathology were recorded.  
Differences in mean tumor size among the three race groups were first assessed with one-
way analysis of variance (ANOVA).  ANOVA was followed by pairwise comparisons to 
assess the individual mean differences between two race groups.  Student t test was 
performed to compare mean difference in tumor size between pathology and imaging.  In 
addition, non-parametric tests were also employed to check for these differences.  Non-
parametric tests are based on fewer assumptions such as they do not assume that the 
outcome is approximately normally distributed.  Non-parametric Kruskal-Wallis was 
used to assess for differences in distribution of tumor size by race.  Dwass, Steel, 
Critchlow-Fligner multiple comparison procedure was used to perform pairwise 
comparisons between the three race groups.  Lastly, non-parametric Mann–Whitney U 
test was applied to compare median difference in tumor size between pathology and 
imaging. 
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This method happened to be best in trying to address many factors that tend to 
promote higher chances of cancer occurrence among human beings.  By comparing 
White, Haitian and Black Americans, an element of race and cancer occurrence will have 
been addressed.  This is justified by the fact that prevalence of cancer is determined by a 
number of factors such the prevailing environmental condition, lifestyles, individual 
economic levels and general well-being in a given society.  Sampling of the three races 
presents an element of significance during the real process of data analysis (Wilkinson, 
1999).  This method has been effective in comparing the prevalence of cancer in both 
male and female gender.  This method was chosen to whether or not cancer is more 
common in females or male gender.   
This IRB approved study used the hospital electronic medical records and the 
cancer registry to reduce chances of bias and errors that might occur during the process of 
analyzing collected data.  This forms the proper base for making compared statistical 
correlations between males and females; in the three races that were being compared 
(Wilkinson, 1999).  
Rationale for Use of ANOVA 
Analysis of variance is a collection of statistical models used by researchers to 
determine means of groups with their respective associated features (Wilkinson, 1999).  
The one-way analysis of variance is used to determine whether there are any statistically 
significant differences among the means of three or more independent groups. 
There are numerous advantages associated with use of ANOVA as a statistical 
tool for determining the mean of individual groups.  First and foremost, ANOVA test is 
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statistically flexible and less robust thus limited chances of violating its scientific 
assumptions (Wilkinson, 1999).  For example, standard error for the difference between 
pairs of groups is based upon the within group mean square.  As this has more degrees of 
freedom than a standard error based upon the two groups alone, ANOVA has greater 
power to find a difference if one exists compared to a student t test.  Evidently, ANOVA 
has acclimatized to the analysis of variety of experimental designs thus it is the most used 
statistical tool in psychological research works.  
The Student t-test  
A Student t-test has the potential to assess the possibility of the means of two 
groups being statistically different from one another (Flom, 2017).  Use of this test 
determined the difference in tumor size between pathology and imaging.  Advantages of 
t-tests lie in the ease of interpretation of gathered and analyzed data and simplicity in 
terms ease of calculations.  
Kruskal-Wallis and Mann-Whitney U Test 
Kruskal-Wallis test was of importance in testing whether the mean ranks of the 
Haitian, Whites and Black American patients were same or not.  It is a non-parametric 
test which assesses whether the three samples originate from the same distribution.  This 
tool is very important in trying to meet an aspect of normality that ANOVA might have 
failed to address (Wilkinson, 1999).  The aspect of this test of being non-parametric is 
what motivated me to include it in my research; for purposes of reaching at 
comprehensive results and corroborating findings from analysis performed using 
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parametric techniques such as ANOVA and Student t-test. Dwass, Steel, Critchlow-
Fligner multiple comparison procedure, which is based on pairwise two-sample rankings, 
was performed to look for differences in ranks between two individual race groups.  The 
Mann-Whitney U is the non-parametric equivalent of the independent samples t-test.  The 
test does not assume any properties regarding the distribution of the dependent variable in 
the analysis.  In contrast to the t-test, it does not compare mean scores but median scores 
of two samples (pathology and imaging).  Both these non-parametric tests-ensure that 
skewed data is well analyzed and presented in the proper manner without necessity of 
data being normally distributed (Wilkinson, 1999).  It should be noted that the success of 
the results of the analyzed data is dictated by proper use of the tools.  
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RESULTS 
 
 
In Table 1 the comparison of the tumor size is illustrated based by race/ethnicity 
and based on imaging, the P in the table shows us the overall of tumor size in 3 different 
population: with individual comparison of White (W), Black(B), and Haitian (H).  The 
tumor size in Haitian subjects is significantly larger on imaging than on (in mean and 
median).  This information is based on 125 patients who had complete imaging late.  The 
tumor is significantly larger in Haitian women than in Black and Hispanic women.  The 
tumor size from pathology or imaging are shown by mean, standard deviation (SD) and 
median inter-quartile range (IQR).  The difference in tumor size was shown by 
race/ethnicity using analysis of variance.  We analyzed by pair wise comparison or by 
student's t-tests.  To assess differences in distribution of tumor size by race/ethnicity text 
methods such as Non-parametric Mann–Whitney U test or Kruskal-Wallis were used. 
 
Table 1. The difference in tumor size based on race/ethnicity 
 
  n USA-born 
White 
(N=49) 
n USA-born 
Black 
(N=51) 
n Haitian 
(N=68) 
P* 
  mean (SD) 
Tumor size by 
pathology (cm)1  32 
1.61 
(1.22) 49 
1.54  
(1.17) 
6
8 
2.09 
(1.65) 0.086 
Tumor size by  
imaging (cm)2 42 
1.88 
(1.26) 43 
2.07  
(1.77) 
5
7 
3.09 
(2.91) 0.013 
 median (inter quartile range) 
Tumor size by 
pathology (cm)3  32 
1.2 
 (1.2) 49 
1.3  
(0.60) 
6
8 
2.25 
(2.0) 0.202 
Tumor size by  
imaging (cm)4 42 
1.4 
(1.5) 43 
1.6 
(1.4) 
5
7 
2.30 
(2.7) 0.034 
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Note: Abbreviations: N= total number of patients; n= number of patients with data; cm= 
centimeter; SD=standard deviation 
 
Pairwise comparisons: 
1W vs. B=0.838; W vs. H=0.117; B vs. H= 0.042 
2W vs. B=0.703; W vs. H=0.008; B vs. H= 0.022 
3W vs. B=0.996; W vs. H=0.439; B vs. H= 0.215 
4W vs. B=0.992; W vs. H=0.058; B vs. H= 0.088 
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DISCUSSION 
 
Haitian Breast Cancer patients present with significantly larger tumors when 
compared to other patient populations.  The results support that previous tumor size 
varies in different sub populations.  The results show that Haitian patients had larger 
tumor size than Black and White patients.  These results confirm the previously published 
data.  
Pervious publications have shown that age specific breast cancer incidence rate 
for African-American women under age 35 is more than twice the rate for White women 
of similar age.  Although incidence of breast cancer is lower among Black women 
compared with White women, higher mortality rates were observed among Black 
women, partly due to being diagnosed at later stages and to having lower stage-specific 
survival.  There is need for design and implementation of effective medical plans to curb 
the widespread of cancer in society.  For example, enhanced patient education and 
intensified out-reach programs are needed to counteract this marked delay in initial 
diagnosis and treatment.   
This study underscores that patient education and intensified out-reach programs 
are needed to counteract this marked delay in initial diagnosis and treatment.  Better 
education and intensified outreach programs tailored to the Haitian sub-population in the 
U.S. are needed to counteract apparent delays in diagnosis and treatment of breast cancer. 
Further studies are needed to determine the co-factors contributing to the results 
including medical education.  The study conformed Haitian patients present later to 
medical care providers therefore receiving cancer treatment later than other populations. 
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This may be caused by several factors such as; lack of available healthcare, education, 
socio-economic, and cultural impact across the groups.  These considerations contribute 
to further research, impactful component and a complete assessment of different genetic 
and other physiological and medical co-factors. 
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